Kannan Rangaramanujam

Johns Hopkins University

NIH Rank #4515
  • Program Leader
  • R01 Holder
  • Translational
  • Early Career

NIH Funding · FY2024

Total Funding
$2.2M
Fiscal year 2024
Grants Awarded
5
Active NIH grants
National Rank
#4,515
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.2M across 5 grants · National rank #4515.

Top grants by award amount

Kannan Rangaramanujam's NIH grant portfolio, ranked by award amount.

  • 5R01AG078181-03R01
    Macrophage-targeted dendrimer 2-PMPA for the treatment of age-related sarcopenia
    $580.2K
    award amount
  • 5R01NS093416-08R01
    Targeting glutamate carboxypeptidase in perinatal brain injury
    $552.3K
    award amount
  • 1R01NS139204-01R01
    Novel Glucose dendrimers for targeting injured neurons
    $519.5K
    award amount
  • 5R01AG063831-05R01
    Dendrimer-conjugated nSMase2 inhibitor as a novel therapeutic approach for Alzheimer's Disease
    $471.4K
    award amount
  • 5P30EY001765-49P30
    P30 Wilmer Core Grant for Vision Research
    $77.8K
    award amount

Affiliation

Institutions that have administered grants for Kannan Rangaramanujam.

Affiliated with Johns Hopkins University (MD).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Johns Hopkins University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4515
  6. 2024
    Entered Top 25% Nationally
    Ranked #4515